Pradelli, Lorenzo, et al. “Albutrepenonacog Alfa (Idelvion®) for the Treatment of Italian Patients With Hemophilia B: A Budget Impact Model”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 19, no. 1, Jan. 2018, doi:10.7175/fe.v19i1.1328.